GlassScriptPhysician profile
Tashia Sperry
NPI 1619304128
$2,839.77
in general payments reported to CMS, 2019-2025
17 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $28.10 · 2024: $1,093 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,611 · Education: $87.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,610.63 |
| Education | $87.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,462.09 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $300.39 | 2024-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $252.36 | 2024-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Abbott Laboratories | $203.72 | 2024-2025 | Infinity |
| Globus Medical, INC. | $141.65 | 2022 | |
| Pfizer INC. | $112.80 | 2024-2025 | |
| Lilly USA, LLC | $72.38 | 2024-2025 | Kisunla, Emgality, Reyvow |
| Incyte Corporation | $52.83 | 2024 | Opzelura |
| Genzyme Corporation | $41.79 | 2024 | |
| Novartis Pharmaceuticals Corporation | $41.00 | 2024 | |
| Janssen Biotech, INC. | $28.10 | 2023 | Tremfya |
| Acadia Pharmaceuticals INC | $25.23 | 2025 | Nuplazid |
| Arcutis Biotherapeutics, INC. | $24.38 | 2024 | Zoryve |
| Otsuka America Pharmaceutical, INC. | $22.67 | 2025 | Rexulti |
| Biogen, INC. | $21.01 | 2025 | Spinraza, Qalsody |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $18.88 | 2025 | Rexulti |
| Philips North America LLC | $18.49 | 2025 | Extended Holter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tashia Sperry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.